Optimistic Outperform Rating on Sarepta Therapeutics Amid Strong Elevidys Demand and Potential Label Expansion
TipRanksApr 26 02:07 ET
Bullish Sarepta Therapeutics Insiders Loaded Up On US$13.3m Of Stock
Yahoo FinanceApr 25 09:55 ET
Sarepta Therapeutics to Announce First Quarter 2024 Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. 24, 2024-- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report first quarter 2024 financial result
Sarepta TherapeuticsApr 24 00:00 ET
Edgewise Gets EU Orphan Drug Status for Muscular Dystrophy Drug
Seeking AlphaApr 23 10:29 ET
Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV), Sarepta Therapeutics (SRPT) and Intuitive Surgical (ISRG)
TipRanksApr 19 07:12 ET
As More Rare Disease Therapies Launch, Their Prices Are Rising
Seeking AlphaApr 16 12:22 ET
10 Unstoppable Stocks That Will Make You Richer
Yahoo FinanceApr 13 21:39 ET
Unusual Options Activity: SRPT, C and Others Attract Market Bets, SRPT V/OI Ratio Reaches 66.7
EST Apr 11th Morning Delivery - In the last two hours of trading, 6 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.O
moomoo NewsApr 11 11:30 ET
Sarepta Therapeutics' (NASDAQ:SRPT) Investors Will Be Pleased With Their Respectable 72% Return Over the Last Three Years
One simple way to benefit from the stock market is to buy an index fund. But many of us dare to dream of bigger returns, and build a portfolio ourselves. For example, Sarepta Therapeutics, Inc. (NAS
Simply Wall StApr 11 10:10 ET
Sarepta Therapeutics: A Buy Recommendation Amidst Undervaluation and Growth Potential for Elevidys
TipRanksApr 10 02:19 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bluebird Bio (BLUE), Sarepta Therapeutics (SRPT) and Jazz Pharmaceuticals (JAZZ)
TipRanksApr 8 22:00 ET
Unusual Options Activity: SRPT, SBUX and Others Attract Market Bets, SRPT V/OI Ratio Reaches 96.2
EST Apr 8th Morning Delivery - In the last two hours of trading, 7 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.Of
moomoo NewsApr 8 11:30 ET
2 Biotech Stocks to Buy Hand Over Fist in April
Yahoo FinanceApr 6 08:45 ET
Buy Rating on Sarepta Therapeutics Amidst Anticipated Drug Approval and Market Potential
TipRanksApr 4 19:46 ET
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
BenzingaApr 4 13:35 ET
Outperforming ETF Manager Names a Potential '50-bagger' in the Stock Market
By Philip van Doorn Michael Taylor runs the Simplify Health Care ETF, which donates its management fees to Susan G. Komen for the Cure to fund breast-cancer research and help people with the disease
MarketWatchApr 2 07:04 ET
Solid Biosciences Gets FDA Rare Pediatric Disease Status for DMD Therapy
Seeking AlphaApr 1 10:17 ET
Sarepta Therapeutics (SRPT) Up 1.2% Since Last Earnings Report: Can It Continue?
Yahoo FinanceMar 29 11:30 ET
Sarepta Therapeutics' (NASDAQ:SRPT) Growing Losses Don't Faze Investors as the Stock Increases 3.6% This Past Week
Yahoo FinanceMar 29 09:12 ET
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar. 29, 2024-- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on March 29, 2024 that we
Sarepta TherapeuticsMar 29 00:00 ET
No Data
No Data